Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
At publication ·
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) · proxy filed
At a glance
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Adagio Medical Holdings, Inc.'s stock currently trades at $0.13 with a market capitalization of $15.2M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Adagio Medical Holdings, Inc.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Adagio Medical Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADGM Stock Page
Browse all filings on our ADGM SEC filings page.
Public companies like Adagio Medical Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
earnings ·
Current market data
NASDAQ · ADGM
$0.09
Unchanged: $0.00 · 0.00%
Live quote updated
